Role of Hyperbaric Oxygen in Filler-Induced Vascular Occlusion.
Filler
Filler-induced complications
Hyperbaric oxygen
Vascular occlusion
Journal
Aesthetic plastic surgery
ISSN: 1432-5241
Titre abrégé: Aesthetic Plast Surg
Pays: United States
ID NLM: 7701756
Informations de publication
Date de publication:
08 Mar 2024
08 Mar 2024
Historique:
received:
03
12
2023
accepted:
09
02
2024
medline:
9
3
2024
pubmed:
9
3
2024
entrez:
8
3
2024
Statut:
aheadofprint
Résumé
The rising incidence of filler-induced vascular complications in the context of aesthetic procedures necessitates a thorough assessment of therapeutic options. Hyperbaric oxygen therapy (HBOT) has emerged as a potential intervention for filler-induced vascular occlusion (FIVO), although optimal dosing and timing remain undefined. This review explores the pathophysiology of FIVO and elucidates HBOT's multifaceted role in salvaging ischemic tissue. The physical and biochemical mechanisms of HBOT, including its vasodilatory, anti-spasmodic, and anti-inflammatory effects, are examined. HBOT serves as an adjunctive therapy in FIVO management, emphasizing timely intervention, adherence to specific pressures (two atmosphere absolute), and session durations (60 minutes) to optimize efficacy and minimize complications. While existing HBOT protocols for compromised grafts provide insights, standardized guidelines for FIVO are lacking. HBOT enhances tissue oxygenation, modulates reactive oxygen species, and influences angiogenesis and hypoxia response. However, it does not replace key treatment protocols for filler vascular complications. Further research and standardized protocols are warranted to define HBOT's definitive role in mitigating filler-induced vascular complications. Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Identifiants
pubmed: 38459381
doi: 10.1007/s00266-024-03920-7
pii: 10.1007/s00266-024-03920-7
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. Springer Science+Business Media, LLC, part of Springer Nature and International Society of Aesthetic Plastic Surgery.
Références
Soares DJMD (2022) Bridging a century-old problem: the pathophysiology and molecular interventions. Molecules 27(17):5398. https://doi.org/10.3390/molecules27175398
doi: 10.3390/molecules27175398
pubmed: 36080164
Heydenrych I, De Boulle K, Kapoor KM, Bertossi D (2021) The 10-point plan 2021: updated concepts for improved procedural safety during facial filler treatments. Clin Cosmet Investig Dermatol 6(14):779–814. https://doi.org/10.2147/CCID.S315711
doi: 10.2147/CCID.S315711
Mathieu D, Marroni A, Kot J (2017) Tenth European Consensus Conference on Hyperbaric Medicine: recommendations for accepted and non-accepted clinical indications and practice of hyperbaric oxygen treatment. Diving Hyperb Med 47(1):24–32
pubmed: 28357821
pmcid: 6147240
Moon RE (2019) Hyperbaric oxygen theraphy indications, 14th edn. Undersea and Hyperbaric Medical Society
Sociedad Americana de Cirujanos Plásticos (2020) Informe de estadísticas de cirugía plástica
The Aesthetic Society (2022) The procedural statistics of Aesthetic Plastic Surgery National Databank Statistics for 2022
U.S. Food and Drug Administration (2021) FDA executive summary general issues panel meeting on dermal fillers 2021
De la Guardia C, Virno A, Musumeci M, Bernardin A, Silberberg MB (2022) Rheologic and physicochemical characteristics of hyaluronic acid fillers: overview and relationship to product performance. Facial Plast Surg 38(2):116–123. https://doi.org/10.1055/s-0041-1741560
doi: 10.1055/s-0041-1741560
pubmed: 35114708
pmcid: 9188840
Chiang C, Zhou S, Liu K (2016) Intravenous hyaluronidase with urokinase as treatment for arterial hyaluronic acid embolism. Plast Reconstr Surg 137(1):114–121. https://doi.org/10.1097/PRS.0000000000001931
doi: 10.1097/PRS.0000000000001931
pubmed: 26710015
Nie F, Xie H, Wang G, An Y (2019) Risk comparison of filler embolism between polymethyl methacrylate (PMMA) and hyaluronic acid (HA). Aesthet Plast Surg 43(3):853–860. https://doi.org/10.1007/s00266-019-01320-w
doi: 10.1007/s00266-019-01320-w
De la Motte C, Nigro J, Vasanji A, Rho H, Kessler S, Bandyopadhyay S, Danese S, Fiocchi C, Stern R (2009) Platelet-derived hyaluronidase 2 cleaves hyaluronan into fragments that trigger monocyte-mediated production of proinflammatory cytokines. Am J Pathol 174(6):2254–2264. https://doi.org/10.2353/ajpath.2009.080831
doi: 10.2353/ajpath.2009.080831
pubmed: 19443707
pmcid: 2684190
Lima VGF, Regattieri NAT, Pompeu MF, Costa IMC (2019) External vascular compression by hyaluronic acid filler documented with high-frequency ultrasound. J Cosmet Dermatol 18(6):1629–1631. https://doi.org/10.1111/jocd.12901
doi: 10.1111/jocd.12901
pubmed: 30838729
Schelke LW, Velthuis P, Kadouch J, Swift A (2023) Early ultrasound for diagnosis and treatment of vascular adverse events with hyaluronic acid fillers. J Am Acad Dermatol 88(1):79–85. https://doi.org/10.1016/j.jaad.2019.07.032
doi: 10.1016/j.jaad.2019.07.032
pubmed: 31325548
Jajoria H, Venkataram A, Mysore V (2020) Importance of choke vessels in injectable fillers. J Cutan Aesthet Surg. 13(3):185–190. https://doi.org/10.4103/JCAS.JCAS_73_19
doi: 10.4103/JCAS.JCAS_73_19
pubmed: 33208993
pmcid: 7646430
Taylor GI, Corlett RJ, Ashton MW (2017) The functional angiosome: clinical implications of the anatomical concept. Plast Reconstr Surg 140(4):721–733. https://doi.org/10.1097/PRS.0000000000003694
doi: 10.1097/PRS.0000000000003694
pubmed: 28953725
Hwang K (2016) Hyperbaric oxygen therapy to avoid blindness from filler injection. J Craniofac Surg 27(8):2154–2155. https://doi.org/10.1097/SCS.0000000000003089
doi: 10.1097/SCS.0000000000003089
pubmed: 28005776
Mori K, Ohta K, Nagano S, Toshinori M, Yago T, Ichinose Y (2007) A case of ophthalmic artery obstruction following autologous fat injection in the glabellar area. Nippon Ganka Gakkai Zasshi 111(1):22–25
pubmed: 17305092
Nonomura S, Oshitari T, Miura G, Chiba A, Yamamoto S (2014) A case of ophthalmic artery occlusion following injection of hyaluronic acid into the glabellar area. Nippon Ganka Gakkai Zasshi 118(9):783–787
pubmed: 25318187
Celebi AR, Kilavuzoglu AE, Altiparmak UE, Cosar CB, Ozkiris A (2016) Hyperbaric oxygen for the treatment of the rare combination of central retinal vein occlusion and cilioretinal artery occlusion. Diving Hyperb Med 46(1):50–53
pubmed: 27044464
Hayreh SS, Weingeist TA (1980) Experimental occlusion of the central artery of the retina. IV: retinal tolerance time to acute ischaemia. Br J Ophthalmol 64(11):818–825. https://doi.org/10.1136/bjo.64.11.818
doi: 10.1136/bjo.64.11.818
pubmed: 7426553
pmcid: 1043826
Navarro-Hernandez E, Pérez-López M (2022) Effectiveness of retrobulbar hyaluronidase in the treatment of visual loss caused by periocular hyaluronic acid injection. A systematic review. Arch Soc Esp Oftalmol (Engl Ed) 97(9):521–538. https://doi.org/10.1016/j.oftale.2022.06.005
doi: 10.1016/j.oftale.2022.06.005
pubmed: 35787383
Justice J Jr, Lehmann RP (1976) Cilioretinal arteries: a study based on review of stereo fundus photographs and fluorescein angiographic findings. Arch Ophthalmol 94(8):1355–1358. https://doi.org/10.1001/archopht.1976.03910040227015
doi: 10.1001/archopht.1976.03910040227015
pubmed: 949278
Wang RS (1991) Cilioretinal arteries under fundus fluorescein angiography. Zhonghua Yan Ke Za Zhi 27(4):219–220
pubmed: 1935448
Stoffelns BM, Laspas P (2015) Cilioretinal artery occlusion. Klin Monbl Augenheilkd 232(4):519–524. https://doi.org/10.1055/s-0034-1396327
doi: 10.1055/s-0034-1396327
pubmed: 25902112
Patz A (1955) Oxygen inhalation in retinal arterial occlusion; a preliminary report. Am J Ophthalmol 40(6):789–795. https://doi.org/10.1016/0002-9394(55)91107-7
doi: 10.1016/0002-9394(55)91107-7
pubmed: 13268578
Weaver LK (ed) (2014) Hyperbaric oxygen therapy indications: the hyperbaric oxygen therapy committee report, 13th edn. Best Publishing Company, North Palm Beach
Basset B, Bennett P (1977) Introduction to the physical and physiological basis of hyperbaric therapy o Title. In: Davis J, Hunt T (eds) Hyperbaric oxygen therapy. Undersea and Hyperbaric Medical Society, Betesda, pp 11–24
Krogh A (1919) The number and distribution of capillaries in muscles with calculations of the oxygen pressure head necessary for supplying the tissue. J Phisiol 52:409–415
doi: 10.1113/jphysiol.1919.sp001839
Kawamura M, Sakakibara K, Yusa T (1978) Effect of increased oxygen on peripheral circulation in acute, temporary limb hypoxia. J Cardiovasc Surg (Torino) 19(2):161–168
pubmed: 659492
Rosas RR, Flanagan CE, Odland RM (2007) R109: Reduction of edema with hyperbaric gas-induced osmosis. Otolaryngol–Head and Neck Surg 137(2_suppl):P188
Shinomiya N, Asai Y (2020) Hyperbaric oxygenation therapy [internet]. In: Shinomiya N, Asai Y (eds) Hyperbaric oxygenation therapy: molecular mechanisms and clinical applications. Springer, Singapore, pp 6–7
doi: 10.1007/978-981-13-7836-2
Steenebruggen F, Jacobs D, Delporte C, Van Antwerpen P, Boudjeltia KZ, Biston P et al (2023) Hyperbaric oxygenation improve red blood cell deformability in patients with acute or chronic inflammation. Microvasc Res 148:104534
doi: 10.1016/j.mvr.2023.104534
pubmed: 37030528
Thom SR (2009) Oxidative stress is fundamental to hyperbaric oxygen therapy. J Appl Physiol 106(3):988–995
doi: 10.1152/japplphysiol.91004.2008
pubmed: 18845776
Hadanny A, Efrati S (2020) The hyperoxic-hypoxic paradox. Biomolecules 10(6):958
doi: 10.3390/biom10060958
pubmed: 32630465
pmcid: 7355982
Wang GL, Semenza GL (1993) Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J Biol Chem 268(29):21513–21518
doi: 10.1016/S0021-9258(20)80571-7
pubmed: 8408001
Kleban S, Baynosa RC (2020) The effect of hyperbaric oxygen on compromised grafts and flaps. Undersea Hyperb Med 47(4):635–648. https://doi.org/10.22462/10.12.2020.13
doi: 10.22462/10.12.2020.13
pubmed: 33227840
Jones MW, Cooper JS (2023) Hyperbaric therapy for skin grafts and flaps. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island
Memar MY, Yekani M, Alizadeh N, Baghi HB (2019) Hyperbaric oxygen therapy: antimicrobial mechanisms and clinical application for infections. Biomed Pharmacother 109:440–447. https://doi.org/10.1016/j.biopha.2018.10.142
doi: 10.1016/j.biopha.2018.10.142
pubmed: 30399579
Bumah VV, Whelan HT, Masson-Meyers DS, Quirk B, Buchmann E, Enwemeka CS (2015) El efecto bactericida de la luz de 470 nm y el oxígeno hiperbárico en el Staphylococcus aureus resistente a la meticilina (MRSA). Láseres Med Ciencia 30(3):1153–1159
Kellogg RH (1978) La pression barométrique: Paul Bert’s hypoxia theory and its critics. Respir Physiol 34(1):1–28
doi: 10.1016/0034-5687(78)90046-4
pubmed: 360338
Sheffield PJ (2004) How the Davis 2.36 ATA wound healing enhancement treatment table was established. Undersea Hyperb Med 31(2):193–194
pubmed: 15485079
Boerema I, Brummelkamp W, Meijne N (1964) Clinical application of hyperbaric oxygen. Elsevier, New York, p 427
Madero J, Salvador M (2022) Capítulo 15. Intoxicaciones por gases respiratorios y otros. In: Marin MS (ed) Manual de Medicina Subacuática. Amazing BooKs
Celebi ARC (2021) Hyperbaric oxygen therapy for central retinal artery occlusion: patient selection and perspectives. Clin Ophthalmol 13(15):3443–3457. https://doi.org/10.2147/OPTH.S224192
doi: 10.2147/OPTH.S224192
Murphy-Lavoie H, Butler F, Hagan C (2012) Central retinal artery occlusion treated with oxygen: a literature review and treatment algorithm. Undersea Hyperb Med 39(5):943–953
pubmed: 23045923
Henderson R, Reilly DA, Cooper JS (2018) Hyperbaric oxygen for ischemia due to injection of cosmetic fillers: case report and issues. Plast Reconstr Surg Glob Open 6(1):e1618. https://doi.org/10.1097/GOX.0000000000001618
doi: 10.1097/GOX.0000000000001618
pubmed: 29464158
pmcid: 5811288
Oley MH, Oley MC, Mawu FO, Aling DMR, Faruk M (2022) Hyperbaric oxygen therapy in managing minimally invasive aesthetic procedure complications: a report of three cases. Clin Cosmet Investig Dermatol 14(15):63–68. https://doi.org/10.2147/CCID.S344408
doi: 10.2147/CCID.S344408
Worley N, Lupo M, Holcomb K, Kullman G, Elahi E, Elison J (2020) Hyperbaric oxygen treatment of keratitis following facial hyaluronic acid injection. Ochsner J. 20(2):193–196. https://doi.org/10.31486/toj.18.0133
doi: 10.31486/toj.18.0133
pubmed: 32612475
pmcid: 7310167
Jalilian F, Hetz SP, Bostwick J, Boet S (2022) Hyperbaric oxygen therapy for treatment of a late presenting ischaemic complication from hyaluronic acid cosmetic filler injection. BMJ Case Rep 15(7):e249190. https://doi.org/10.1136/bcr-2022-249190
doi: 10.1136/bcr-2022-249190
pubmed: 35798493
Simman R, Bach K (2022) Role of hyperbaric oxygen therapy in cosmetic and reconstructive surgery in ischemic soft tissue wounds: a case series. Eplasty 22:e61
pubmed: 36545638
pmcid: 9748824
Hong WT, Kim J, Kim SW (2019) Minimizing tissue damage due to filler injection with systemic hyperbaric oxygen therapy. Arch Craniofac Surg 20(4):246–250. https://doi.org/10.7181/acfs.2019.00059
doi: 10.7181/acfs.2019.00059
pubmed: 31462016
pmcid: 6715552
Wang HC, Wang Y, Long X, Wang X (2021) Mandibular osteomyelitis after hyaluronic acid injection. J Cosmet Dermatol 20(2):457–459. https://doi.org/10.1111/jocd.13575
doi: 10.1111/jocd.13575
pubmed: 32592232
Uittenbogaard D, Lansdorp CA, Bauland CG, Boonstra O (2019) Hyperbaric oxygen therapy for dermal ischemia after dermal filler injection with calcium hydroxylapatite: a case report. Undersea Hyperb Med 46(2):207–210
doi: 10.22462/04.06.2019.15
pubmed: 31051067
Alves DD, Menezes HS, Chacur R, Mafaldo RC, Chacur NMBDS, Gomes LD, Nardi R, de Castro GAM, Borges VPB, Gomes MGD (2021) Vascular complications with injection implants: treatment with hyperbaric chamber. Case Rep Plast Surg Hand Surg 8(1):81–86. https://doi.org/10.1080/23320885.2021.1933492
doi: 10.1080/23320885.2021.1933492
McGuire LK, Hale EK, Godwin LS (2013) Post-filler vascular occlusion: a cautionary tale and emphasis for early intervention. J Drugs Dermatol 12(10):1181–1183
pubmed: 24085057
Rodriguez-Valera A, Nieto-Lopez F (2023) Hyperbaric oxygenation therapy improve recovery in early or late vascular occlusion generates by tissue fillers. J Cosmet Dermatol. https://doi.org/10.1111/jocd.15677
doi: 10.1111/jocd.15677
pubmed: 36760160
Kruize RGF, Teguh DN, van Hulst RA (2020) Hyperbaric oxygen therapy in hyaluronic acid filler-induced dermal ischemia. Dermatol Surg 46(12):1755–1757. https://doi.org/10.1097/DSS.0000000000002109
doi: 10.1097/DSS.0000000000002109
pubmed: 31490298
Darling MD, Peterson JD, Fabi SG (2014) Impending necrosis after injection of hyaluronic acid and calcium hydroxylapatite fillers: report of 2 cases treated with hyperbaric oxygen therapy. Dermatol Surg 40(9):1049–1052. https://doi.org/10.1097/01.DSS.0000452637.52575.16
doi: 10.1097/01.DSS.0000452637.52575.16
pubmed: 25077741
Fakih-Gomez N, Porcar Plana CA, Verano-Garcia A, Muñoz-Gonzalez C, Kadouch J (2023) Updated filler emergency kit: next-generation emergency solution. Aesthetic Plast Surg. https://doi.org/10.1007/s00266-023-03722-3
doi: 10.1007/s00266-023-03722-3
pubmed: 37957396